Evidence map›Paper›PMID 41585622›Full record

ArticleCureus2026

Causes of Visual Loss in Uveitis: A Retrospective Study at a Tertiary Referral Centre.

Mohammed Al-Roubaie, Nicholas Beare

Abstract read
In one paragraph

Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Mohammed Al-RoubaieOphthalmology, Northwick Park Hospital, London, GBR.
Nicholas BeareOphthalmology, Liverpool University Hospitals NHS Foundation Trust, Liverpool, GBR.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeThe purpose of the study is to determine the causes of visual loss in patients with uveitis attending a tertiary referral clinic and to assess the relative contribution of uveitis-related inflammation versus its complications, stratified by uveitis subtype.

methodsThis retrospective, cross-sectional study reviewed the medical records of 442 patients attending the uveitis service at St Paul's Eye Unit, Royal Liverpool University Hospital. Demographic data, uveitis classification, laterality, systemic treatment, and visual outcomes were extracted from MediSIGHT, an electronic medical records system. Visual impairment was classified using the most recent recorded visual acuity, and causes of visual loss were analysed descriptively.

resultsAmong 442 patients (mean age 52 years; 51.6% female), 148 (33.5%) had visual loss in at least one eye, including 64 (14.5%) with moderate visual impairment, 13 (2.9%) who were sight-impaired, and 71 (16.1%) who were severely sight-impaired. Cystoid macular oedema (33.1%) and cataract or aphakia (24.3%) were the most common causes, together accounting for 57.4% of visual loss. Visual loss occurred most frequently in posterior uveitis (53.1%), compared with anterior uveitis (19.6%;

conclusionVisual loss remains a common outcome in patients with uveitis, most frequently arising from disease-related complications such as cystoid macular oedema and cataract. Posterior uveitis and panuveitis are associated with the highest risk of impairment. These findings highlight the ongoing burden of uveitis-related visual morbidity within tertiary care settings.

Indexed as

blindnesscataractcystoid macular oedemaepidemiologyuveitisvisual loss

Identifiers

PMID41585622
PMCPMC12831035

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.